Asset Allocation

As of December 31, 2025.
Type % Net
Cash 3.53%
Stock 61.62%
Bond 28.92%
Convertible 0.00%
Preferred 5.23%
Other 0.70%
View Asset Allocation
Start Trial

Market Capitalization

As of December 31, 2025
Large 51.37%
Mid 28.52%
Small 20.10%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 94.45%    % Emerging Markets: 0.65%    % Unidentified Markets: 4.90%

Americas 60.34%
58.46%
Canada 14.79%
United States 43.67%
1.88%
As of December 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 33.04%
United Kingdom 2.68%
30.36%
Denmark 1.63%
Finland 3.96%
France 8.84%
Germany 3.98%
Ireland 5.03%
Italy 2.66%
Switzerland 4.27%
0.00%
0.00%
Greater Asia 1.72%
Japan 1.06%
0.01%
Australia 0.00%
0.00%
0.65%
China 0.65%
Unidentified Region 4.90%

Bond Credit Quality Exposure

AAA 0.01%
AA 0.05%
A 34.52%
BBB 36.27%
BB 11.98%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 17.17%
Short Term 0.00%
As of December 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
21.05%
Materials
7.58%
Consumer Discretionary
7.54%
Financials
3.80%
Real Estate
2.13%
Sensitive
52.83%
Communication Services
0.00%
Energy
3.24%
Industrials
33.33%
Information Technology
16.26%
Defensive
25.92%
Consumer Staples
4.13%
Health Care
8.53%
Utilities
13.26%
Not Classified
0.19%
Non Classified Equity
0.00%
Not Classified - Non Equity
0.19%
As of December 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2025
Type % Net
Government 3.31%
Corporate 88.31%
Securitized 0.00%
Municipal 0.00%
Other 8.38%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
15.24%
Less than 1 Year
15.24%
Intermediate
70.99%
1 to 3 Years
30.84%
3 to 5 Years
38.09%
5 to 10 Years
2.07%
Long Term
13.58%
10 to 20 Years
0.00%
20 to 30 Years
0.00%
Over 30 Years
13.58%
Other
0.19%
As of December 31, 2025
View Bond Maturity Exposure
Start Trial